CD14 anti-inflammatory (Cornell)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug NameCD14 anti-inflammatory (Cornell)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonocyte differentiation antigen CD14 inhibitors
TargetsMonocyte differentiation antigen CD14
Therapy Area/IndicationsCrohn DiseaseInflammatory Bowel DiseasesColitis, Ulcerative +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCornell University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCornell University
Active IndicationsN/A
Inactive IndicationsCrohn DiseaseInflammatory Bowel DiseasesColitis, Ulcerative +[4] 

Other Information

ATC CodeN/A
Related LinksN/A